YIH
TMDX icon

Y-Intercept (HK)’s Transmedics TMDX Stock Holding History

Y-Intercept (HK)’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-17,888
Closed -$2.18M – 2056
2025
Q4 		$2.18M Sell
17,888
-6,492
-27% -$815K 0.05% 589
2025
Q3 		$2.74M Sell
24,380
-11,812
-33% -$1.38M 0.07% 444
2025
Q2 		$4.85M Buy
+36,192
New +$3.97M 0.12% 232
2024
Q4 		– Sell
-2,344
Closed -$368K – 1655
2024
Q3 		$368K Buy
+2,344
New +$361K 0.02% 924
2024
Q1 		– Sell
-3,022
Closed -$239K – 1757
2023
Q4 		$239K Buy
+3,022
New +$182K 0.02% 916
2023
Q3 		– Sell
-11,552
Closed -$970K – 1595
2023
Q2 		$970K Buy
11,552
+7,867
+213% +$602K 0.1% 310
2023
Q1 		$279K Buy
+3,685
New +$255K 0.03% 815

Other funds holding TMDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Y-Intercept (HK)'s TMDX Position: Q1 2026 in Review

Y-Intercept (HK) sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 17,888 shares — an estimated $2.18M sold.

Y-Intercept (HK) first reported a position in TMDX in Q1 2023 and held it in 7 quarters. The position peaked at $4.85M in Q2 2025. 414 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Y-Intercept (HK) reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 17,888 Transmedics shares in Q1 2026, an estimated $2.18M.
  • Y-Intercept (HK) first reported a position in Transmedics in Q1 2023 and held it in 7 quarters.
  • Y-Intercept (HK)'s Transmedics position peaked at $4.85M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Y-Intercept (HK)'s 13F filing for Q1 2026, filed 27 Apr 2026.